Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
2021 · Nature · 2,151 citations
https://doi.org/10.1038/s41586-021-03777-9
I
Isabelle Staropoli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
118
Papers
10.1K
Citations
40
h-index
68
i10-index
Isabelle Staropoli is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & HIV Research and Treatment. The author has an h-index of 40, co-authored 101 publications.
ORCID: 0000-0001-8637-4545Papers by this author
worksConsiderable escape of SARS-CoV-2 Omicron to antibody neutralization
2021 · Nature · 1,586 citations
https://doi.org/10.1038/s41586-021-04389-z
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
2024 · Nature Communications · 223 citations
https://doi.org/10.1038/s41467-024-46490-7
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
2023 · Nature Communications · 195 citations
https://doi.org/10.1038/s41467-023-36561-6
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
2021 · Cell Reports Medicine · 92 citations
https://doi.org/10.1016/j.xcrm.2021.100275
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
2022 · The Journal of Experimental Medicine · 66 citations
https://doi.org/10.1084/jem.20220638
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat